The Government of Canada has taken a key step in the fight against cancer thanks to a strategic partnership with Bruce Power and the Saugeen Ojibway Nation. The initiative, announced in Tiverton (Ontario), aims to increase the production of medical isotopes, in particular lutetium-177, used in targeted treatments against several types of cancer.
An investment for medical innovation
With the support of the Strategic Fund for Innovation, the Canadian Medical Isotopes (ECIM) ecosystem benefits from funding up to $ 35 million over five years. This momentum will stimulate the research, development and marketing of isotopes and radiopharmaceuticals, thus strengthening the role of Canada as a world leader in nuclear medicine.
Increased production capacity
The installation of a second system for the production of isotopes to the Bruce Power unit 6 represents a leap forward for the Canadian supply of lutetium-177. First commercial nuclear reactor in the world to produce this isotope, Bruce Power becomes an innovation engine while providing safe and clean electricity.
Economic and social benefits
Beyond the medical dimension, this project contributes to the creation of specialized jobs, the economic development and international influence of Canada in the field of medical isotopes. In 2020, Ottawa had already invested more than $ 2.5 billion in biofabrication and life sciences, testifying to its commitment to building a solid and competitive ecosystem.
A step forward for reconciliation
The participation of the Saugeen Ojibway Nation is an essential component of this partnership. It illustrates the government’s desire to link technological development and reconciliation, by recognizing and valuing the involvement of First Nations in strategic projects.
Source: Innovation, Science and Economic Development Canada
Publication Index Health: 2025-08-19
Number of visits since the publication: 124
Read on health index:
